Prognostic Value of hsa_circ_0007615 in Epithelial Ovarian Cancer and its Regulatory Effect on Tumor Progression

Abstract

This study aimed to interrogate the functional and clinical significance of hsa_circ_0007615 in epithelial ovarian cancer (EOC). GSE192410 was screened for upregulated circRNAs in ovarian cancer. The expression levels of hsa_circ_0007615 were evaluated in a patient cohort comprising 113 EOC tissues and matched normal tissues. Subsequently, the prognostic value was confirmed by the relevance of hsa_circ_0007615 with clinical parameters, Kaplan–Meier analysis and Cox proportional risk model. Cell functional analyses were performed in EOC cell lines using a cell proliferation kit, transwell and cell death kit. Our data revealed that hsa_circ_0007615 was significantly upregulated in EOC tissues and cell lines, compared with normal ones. Multivariate survival analysis revealed that hsa_circ_0007615 emerged as an independent risk factor for overall survival and recurrence of EOC patients. Knockdown of hsa_circ_0007615 in EOC cells led to the blocking of cell proliferation, migration and invasion, but an increase of cell death presenting as ferroptosis. Tumor suppressive effects of hsa_circ_0007615 knockdown can be abolished by miR-874-3p inhibition. TUBB3 was a targeting gene of miR-874-3p. Hsa_circ_0007615 has the functional and clinical significance of EOC. Mechanistically, hsa_circ_0007615 may contribute to EOC by sponging miR-874-3p and moderating TUBB3.

Key words

epithelial ovarian cancer - hsa_circ_0007615 - miR-874-3p - prognosis

Publication History

Received: 16 March 2023

Accepted after revision: 22 June 2023

Article published online:
17 July 2023

• References

• 1 Mazidimoradi A, Momenimovahed Z, Allahqoli L. et al. The global, regional and national epidemiology, incidence, mortality, and burden of ovarian cancer. Health Sci Rep 2022; 5: e936
• 2 Cabasag CJ, Fagan PJ, Ferlay J. et al. Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020. Int J Cancer 2022; 151: 1535-1541
• 3 Baldwin LA, Huang B, Miller RW. et al. Ten-year relative survival for epithelial ovarian cancer. Obstet Gynecol 2012; 120: 612-618
• 4 Lheureux S, Gourley C, Vergote I. et al. Epithelial ovarian cancer. Lancet 2019; 393: 1240-1253
• 5 Sambasivan S. Epithelial ovarian cancer: review article. Cancer Treat Res Commun 2022; 33: 100629
• 6 Natanzon Y, Goode EL, Cunningham JM. Epigenetics in ovarian cancer. Semin Cancer Biol 2018; 51: 160-169
• 7 Yang Q, Yang Y, Zhou N. et al. Epigenetics in ovarian cancer: premise, properties, and perspectives. Mol Cancer 2018; 17: 109
• 8 Nebbioso A, Tambaro FP, Dell'Aversana C. et al. Cancer epigenetics: moving forward. PLoS Genet 2018; 14: e1007362
• 9 Xie W, Sun H, Li X. et al. Ovarian cancer: epigenetics, drug resistance, and progression. Cancer Cell Int 2021; 21: 434
• 10 Liu CX, Chen LL. Circular RNAs: Characterization, cellular roles, and applications. Cell 2022; 185: 2016-2034
• 11 Lei M, Zheng G, Ning Q. et al. Translation and functional roles of circular RNAs in human cancer. Mol Cancer 2020; 19: 30
• 12 Yang Q, Li F, He AT. et al. Circular RNAs: Expression, localization, and therapeutic potentials. Mol Ther 2021; 29: 1683-1702
• 13 Hatibaruah A, Rahman M, Agarwala S. et al. Circular RNAs in cancer and diabetes. J Genet 2021; 100: 21
• 14 Misir S, Wu N, Yang BB. Specific expression and functions of circular RNAs. Cell Death Differ 2022; 29: 481-491
• 15 Guarnerio J, Bezzi M, Jeong JC. et al. Oncogenic role of fusion-circRNAs derived from cancer-associated chromosomal translocations. Cell 2016; 166: 1055-1056
• 16 Garlapati P, Ling J, Chiao PJ. et al. Circular RNAs regulate cancer-related signaling pathways and serve as potential diagnostic biomarkers for human cancers. Cancer Cell Int 2021; 21: 317
• 17 Fang J, Chen W, Meng X. Downregulating circRNA_0044516 inhibits cell proliferation in gastric cancer through miR-149/Wnt1/β-catenin pathway. J Gastrointest Surg 2021; 25: 1696-1705
• 18 Huang G, Liang M, Liu H. et al. CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p/RTKN2 axis and activating Wnt/β-catenin pathway. Cell Death Dis 2020; 11: 1065
• 19 Huang XY, Huang ZL, Huang J. et al. Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis. J Exp Clin Cancer Res 2020; 39: 20
• 20 Peng QS, Cheng YN, Zhang WB. et al. circRNA_0000140 suppresses oral squamous cell carcinoma growth and metastasis by targeting miR-31 to inhibit Hippo signaling pathway. Cell Death Dis 2020; 11: 112
• 21 Wu C, Du M, Yu R. et al. A novel mechanism linking ferroptosis and endoplasmic reticulum stress via the circPtpn14/miR-351-5p/5-LOX signaling in melatonin-mediated treatment of traumatic brain injury. Free Radic Biol Med 2022; 178: 271-294
• 22 Nie W, Li M, Liu B. et al. A circular RNA, circPTPN14, increases MYC transcription by interacting with FUBP1 and exacerbates renal fibrosis. Cell Mol Life Sci 2022; 79: 595
• 23 Qi X, Zhang DH, Wu N. et al. ceRNA in cancer: possible functions and clinical implications. J Med Genet 2015; 52: 710-718
• 24 Zhang L, Yu R, Li C. et al. Circ_0026416 downregulation blocks the development of colorectal cancer through depleting MYO6 expression by enriching miR-545-3p. World J Surg Oncol 2021; 19: 299
• 25 Rothschild G, Zhang W, Lim J. et al. Noncoding RNA transcription alters chromosomal topology to promote isotype-specific class switch recombination. Sci Immunol 2020; 5: eaay5864
• 26 Beg A, Parveen R, Fouad H. et al. Role of different non-coding RNAs as ovarian cancer biomarkers. J Ovarian Res 2022; 15: 72
• 27 Xu H, Tang Y, Liu L. et al. Downregulation of lncRNA ASMTL-AS1 in epithelial ovarian cancer correlates with worse prognosis and cancer progression. Horm Metab Res 2022; 54: 481-488
• 28 Chen L, Shan G. CircRNA in cancer: Fundamental mechanism and clinical potential. Cancer Lett 2021; 505: 49-57
• 29 Kristensen LS, Jakobsen T, Hager H. et al. The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol 2022; 19: 188-206
• 30 Ma H, Qu S, Zhai Y. et al. circ_0025033 promotes ovarian cancer development via regulating the hsa_miR-370-3p/SLC1A5 axis. Cell Mol Biol Lett 2022; 27: 94
• 31 Lyu M, Li X, Shen Y. et al. CircATRNL1 and circZNF608 inhibit ovarian cancer by sequestering miR-152-5p and encoding protein. Front Genet 2022; 13: 784089
• 32 Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 2021; 22: 266-282
• 33 Tabnak P, HajiEsmailPoor Z, Soraneh S. Ferroptosis in lung cancer: from molecular mechanisms to prognostic and therapeutic opportunities. Front Oncol 2021; 11: 792827
• 34 Zhao S, Li P, Wu W. et al. Roles of ferroptosis in urologic malignancies. Cancer Cell Int 2021; 21: 676
• 35 Xia B, Lin M, Dong W. et al. Upregulation of miR-874-3p and miR-874-5p inhibits epithelial ovarian cancer malignancy via SIK2. J Biochem Mol Toxicol 2018; 32: e22168
• 36 Wang Y, Yan C, Qi J. et al. miR-874-3p mitigates cisplatin resistance through modulating NF-κB/inhibitor of apoptosis protein signaling pathway in epithelial ovarian cancer cells. Mol Cell Biochem 2022; 477: 307-317